Tonia C. Carter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tonia C. Carter has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Allen A. Mitchell
Slone Epidemiology Center at Boston University, Boston, MA, USA
2 shared publications - Anne M. Molloy
School of Medicine, Trinity College, Dublin, Ireland
2 shared publications Charlotte M. Druschel
Department of Epidemiology and Biostatistics, School of Public Health, University at Albany – State University of New York, Albany, New York
2 shared publicationsErin M. Bell
Department of Epidemiology and Biostatistics, School of Public Health, University at Albany – State University of New York, Albany, New York
2 shared publicationsFaith Pangilinan
Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
2 shared publicationsJames F. Troendle
Division of Epidemiology, Statistics, and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
2 shared publications
Latest Publications
- Open Access
- 10 December 2010
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (1) , 14-21
Evaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population
Individual studies of the genetics of neural tube defects (NTDs) contain results on a small number of genes in each report. To identify genetic risk factors for NTDs, we evaluated potentially functional single nucleotide polymorphisms (SNPs) that are biologically plausible risk factors for NTDs but that have never been investigated for an association with NTDs, examined SNPs that previously showed no association with NTDs in published studies, and tried to confirm previously reported associations in folate‐related and non‐folate‐related genes. We investigated 64 SNPs in 34 genes for association with spina bifida in up to 558 case families (520 cases, 507 mothers, 457 fathers) and 994 controls in Ireland. Case‐control and mother‐control comparisons of genotype frequencies, tests of transmission disequilibrium, and log‐linear regression models were used to calculate effect estimates. Spina bifida was associated with over‐transmission of the LEPR (leptin receptor) rs1805134 minor C allele [genotype relative risk (GRR): 1.5; 95% confidence interval (CI): 1.0–2.1; P = 0.0264] and the COMT (catechol‐O‐methyltransferase) rs737865 major T allele (GRR: 1.4; 95% CI: 1.1–2.0; P = 0.0206). After correcting for multiple comparisons, these individual test P‐values exceeded 0.05. Consistent with previous reports, spina bifida was associated with MTHFR 677C>T, T (Brachyury) rs3127334, LEPR K109R, and PDGFRA promoter haplotype combinations. The associations between LEPR SNPs and spina bifida suggest a possible mechanism for the finding that obesity is a NTD risk factor. The association between a variant in COMT and spina bifida implicates methylation and epigenetics in NTDs.
- 10 December 2010
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 155 (1) , 14-21
Open AccessEvaluation of 64 candidate single nucleotide polymorphisms as risk factors for neural tube defects in a large Irish study population
Individual studies of the genetics of neural tube defects (NTDs) contain results on a small number of genes in each report. To identify genetic risk factors for NTDs, we evaluated potentially functional single nucleotide polymorphisms (SNPs) that are biologically plausible risk factors for NTDs but that have never been investigated for an association with NTDs, examined SNPs that previously showed no association with NTDs in published studies, and tried to confirm previously reported associations in folate‐related and non‐folate‐related genes. We investigated 64 SNPs in 34 genes for association with spina bifida in up to 558 case families (520 cases, 507 mothers, 457 fathers) and 994 controls in Ireland. Case‐control and mother‐control comparisons of genotype frequencies, tests of transmission disequilibrium, and log‐linear regression models were used to calculate effect estimates. Spina bifida was associated with over‐transmission of the LEPR (leptin receptor) rs1805134 minor C allele [genotype relative risk (GRR): 1.5; 95% confidence interval (CI): 1.0–2.1; P = 0.0264] and the COMT (catechol‐O‐methyltransferase) rs737865 major T allele (GRR: 1.4; 95% CI: 1.1–2.0; P = 0.0206). After correcting for multiple comparisons, these individual test P‐values exceeded 0.05. Consistent with previous reports, spina bifida was associated with MTHFR 677C>T, T (Brachyury) rs3127334, LEPR K109R, and PDGFRA promoter haplotype combinations. The associations between LEPR SNPs and spina bifida suggest a possible mechanism for the finding that obesity is a NTD risk factor. The association between a variant in COMT and spina bifida implicates methylation and epigenetics in NTDs.
- 7 December 2010
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 91 (2) , 108-116
Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects
BACKGROUND: Genital tract infections are common during pregnancy and can result in adverse outcomes including preterm birth and neonatal infection. This hypothesis‐generating study examined whether these infections are associated with selected birth defects. METHODS: We conducted a case‐control study of 5913 children identified as controls and 12,158 cases with birth defects from the National Birth Defects Prevention Study (1997–2004). Maternal interviews provided data on genital tract infections that occurred from one month before pregnancy through the end of the first trimester. Infections were either grouped together as a single overall exposure or were considered as a subgroup that included chlamydia/gonorrhea/pelvic inflammatory disease. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression with adjustment for potential confounders. RESULTS: Genital tract infections were associated with bilateral renal agenesis/hypoplasia (OR, 2.89; 95% CI, 1.11–7.50), cleft lip with or without cleft palate (OR, 1.46; 95% CI, 1.03–2.06), and transverse limb deficiency (OR, 1.84; 95% CI, 1.04–3.26). Chlamydia/gonorrhea/pelvic inflammatory disease was associated with cleft lip only (OR, 2.81; 95% CI, 1.39–5.69). These findings were not statistically significant after adjustment for multiple comparisons. CONCLUSIONS: Caution is needed in interpreting these findings due to the possible misclassification of infection, the limited sample size that constrained consideration of the effects of treatment, and the possibility of chance associations. Although these data do not provide strong evidence for an association between genital tract infections and birth defects, additional research on the possible effects of these relatively common infections is needed. Birth Defects Research (Part A), 2010.
- 7 December 2010
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 91 (2) , 108-116
Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects
BACKGROUND: Genital tract infections are common during pregnancy and can result in adverse outcomes including preterm birth and neonatal infection. This hypothesis‐generating study examined whether these infections are associated with selected birth defects. METHODS: We conducted a case‐control study of 5913 children identified as controls and 12,158 cases with birth defects from the National Birth Defects Prevention Study (1997–2004). Maternal interviews provided data on genital tract infections that occurred from one month before pregnancy through the end of the first trimester. Infections were either grouped together as a single overall exposure or were considered as a subgroup that included chlamydia/gonorrhea/pelvic inflammatory disease. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression with adjustment for potential confounders. RESULTS: Genital tract infections were associated with bilateral renal agenesis/hypoplasia (OR, 2.89; 95% CI, 1.11–7.50), cleft lip with or without cleft palate (OR, 1.46; 95% CI, 1.03–2.06), and transverse limb deficiency (OR, 1.84; 95% CI, 1.04–3.26). Chlamydia/gonorrhea/pelvic inflammatory disease was associated with cleft lip only (OR, 2.81; 95% CI, 1.39–5.69). These findings were not statistically significant after adjustment for multiple comparisons. CONCLUSIONS: Caution is needed in interpreting these findings due to the possible misclassification of infection, the limited sample size that constrained consideration of the effects of treatment, and the possibility of chance associations. Although these data do not provide strong evidence for an association between genital tract infections and birth defects, additional research on the possible effects of these relatively common infections is needed. Birth Defects Research (Part A), 2010.
- 20 November 2009
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 88 (2) , 84-93
Testing reported associations of genetic risk factors for oral clefts in a large Irish study population
BACKGROUND: Suggestive, but not conclusive, studies implicate many genetic variants in oral cleft etiology. We used a large, ethnically homogenous study population to test whether reported associations between nonsyndromic oral clefts and 12 genes (CLPTM1, CRISPLD2, FGFR2, GABRB3, GLI2, IRF6, PTCH1, RARA, RYK, SATB2, SUMO1, TGFA) could be confirmed.METHODS: Thirty‐one single nucleotide polymorphisms (SNPs) in exons, splice sites, and conserved non‐coding regions were studied in 509 patients with cleft lip with or without cleft palate (CLP), 383 with cleft palate only (CP), 838 mothers and 719 fathers of patients with oral clefts, and 902 controls from Ireland. Case‐control and family‐based statistical tests were performed using isolated oral clefts for the main analyses.RESULTS: In case‐control comparisons, the minor allele of PTCH1 A562A (rs2066836) was associated with reduced odds of CLP (odds ratios [OR], 0.29; 95% confidence interval [CI], 0.13–0.64 for homozygotes), whereas the minor allele of PTCH1 L1315P (rs357564) was associated with increased odds of CLP (OR, 1.36; 95% CI, 1.07–1.74 for heterozygotes; and OR, 1.56; 95% CI, 1.09–2.24 for homozygotes). The minor allele of one SUMO1 SNP, rs3769817 located in intron 2, was associated with increased odds of CP (OR, 1.45; 95% CI, 1.06–1.99 for heterozygotes). Transmission disequilibrium was observed for the minor allele of TGFA V159V (rs2166975) which was over‐transmitted to CP cases (p = 0.041).CONCLUSIONS: For 10 of the 12 genes, this is the largest candidate gene study of nonsyndromic oral clefts to date. The findings provide further evidence that PTCH1, SUMO1, and TGFA contribute to nonsyndromic oral clefts. Birth Defects Research (Part A) 2010.
- 20 November 2009
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 88 (2) , 84-93
Testing reported associations of genetic risk factors for oral clefts in a large Irish study population
BACKGROUND: Suggestive, but not conclusive, studies implicate many genetic variants in oral cleft etiology. We used a large, ethnically homogenous study population to test whether reported associations between nonsyndromic oral clefts and 12 genes (CLPTM1, CRISPLD2, FGFR2, GABRB3, GLI2, IRF6, PTCH1, RARA, RYK, SATB2, SUMO1, TGFA) could be confirmed.METHODS: Thirty‐one single nucleotide polymorphisms (SNPs) in exons, splice sites, and conserved non‐coding regions were studied in 509 patients with cleft lip with or without cleft palate (CLP), 383 with cleft palate only (CP), 838 mothers and 719 fathers of patients with oral clefts, and 902 controls from Ireland. Case‐control and family‐based statistical tests were performed using isolated oral clefts for the main analyses.RESULTS: In case‐control comparisons, the minor allele of PTCH1 A562A (rs2066836) was associated with reduced odds of CLP (odds ratios [OR], 0.29; 95% confidence interval [CI], 0.13–0.64 for homozygotes), whereas the minor allele of PTCH1 L1315P (rs357564) was associated with increased odds of CLP (OR, 1.36; 95% CI, 1.07–1.74 for heterozygotes; and OR, 1.56; 95% CI, 1.09–2.24 for homozygotes). The minor allele of one SUMO1 SNP, rs3769817 located in intron 2, was associated with increased odds of CP (OR, 1.45; 95% CI, 1.06–1.99 for heterozygotes). Transmission disequilibrium was observed for the minor allele of TGFA V159V (rs2166975) which was over‐transmitted to CP cases (p = 0.041).CONCLUSIONS: For 10 of the 12 genes, this is the largest candidate gene study of nonsyndromic oral clefts to date. The findings provide further evidence that PTCH1, SUMO1, and TGFA contribute to nonsyndromic oral clefts. Birth Defects Research (Part A) 2010.
- 1 February 2008
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (2) , 191.e1-191.e7
Antifungal drugs and the risk of selected birth defects
- 1 February 2008
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (2) , 191.e1-191.e7
Antifungal drugs and the risk of selected birth defects